CLOs on the Move

Guerbet

www.guerbet.com

 
Guerbet is a Bloomington, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million
  • www.guerbet.com
  • 1185 W 2nd St
    Bloomington, IN USA 47403
  • Phone: 812.333.0059

Executives

Name Title Contact Details
Matt Berkle
Head of U.S. Compliance Profile

Similar Companies

Optogenics Of Syracuse Inc

Optogenics Of Syracuse Inc is a Syracuse, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Amber Pharmacy

Amber Pharmacy is a Omaha, NE-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

AVANCA Medical Devices

AVANCA Medical Devices is a Albuquerque, NM-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Lifespan of Battle Creek

Lifespan of Battle Creek is a Battle Creek, MI-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

BioSig

BioSig Technologies, Inc. (NASDAQ: BSGM) is a medical device company that is developing a proprietary biomedical signal processing technology platform to address an unmet technology need in the rapidly growing $4.6+ billion electrophysiology (EP) marketplace. Led by a proven management team, world-class Board of Directors and Scientific Advisory Board, Los Angeles-based BioSig Technologies is preparing to commercialize its PURE EP™ System. The PURE EP™System is a surface electrocardiogram (ECG) and intracardiac multichannel recording and analysis system designed to assist electrophysiologists in making crucial clinical decisions in real-time by acquiring and displaying high-fidelity cardiac signal recordings even at undetectable levels (until now) with high accuracy to help identify appropriate catheter ablation targets - areas of tissue to destroy that create a heart rhythm disturbance (arrhythmia). BioSig aims to deliver technology to improve upon catheter ablation treatments for the prevalent and potentially deadly arrhythmias, Atrial Fibrillation and Ventricular Tachycardia. PURE EP™ System is an innovative platform, offering potential benefits over current technologies including increased accuracy, reduced noise and interference, clinical information previously not available and potential elimination of the need for repeat procedures. BioSig has partnered with Minnetronix on technology development and has received FDA 510(k) clearance for the PURE EP™ System in August 2018. BioSig Technologies, Inc. is a Nasdaq company: NASDAQ:BSGM.